-
A massive prehistoric snake discovered in India may rank among the largest ever to slither across Earth. Named Vasuki indicus, this ancient giant lived around 47 million years ago and is estimated to have stretched an astonishing 11 to 15 meters long—rivaling the legendary Titanoboa. Fossilized vertebrae unearthed from a lignite mine in Gujarat reveal a thick-bodied, powerful snake likely built for slow, stealthy ambush attacks, similar to modern anacondas.
-
Quantum physics once shocked scientists by revealing that particles can behave like waves—and now, that strange behavior has been pushed even further. For the first time, researchers have observed wave-like interference in positronium, an exotic “atom” made of an electron and its antimatter partner, a positron. This breakthrough not only strengthens the weird reality of quantum mechanics but also opens the door to new experiments involving antimatter, including the possibility of testing how gravity affects it—something never directly measured before.
-
A spectacular cosmic event nicknamed “SN Winny” could help solve one of astronomy’s biggest mysteries: how fast the universe is expanding. This rare superluminous supernova, located 10 billion light-years away, appears five times in the sky thanks to gravitational lensing, creating a dazzling “cosmic fireworks” effect. By measuring the slight delays between each appearance—caused by light taking different paths around two foreground galaxies—scientists can directly calculate the universe’s expansion rate.
-
New experiments suggest that freezing and thawing on early Earth may have helped primitive cell-like structures grow and evolve. Tiny lipid bubbles behaved very differently depending on their membrane makeup—some fused into larger compartments and captured DNA more efficiently. These fusion events could have mixed key molecules, setting the stage for more complex chemistry.
-
A decades-old drug once used to treat sleeping sickness is now showing surprising promise against an ultra-rare and life-threatening genetic disorder called Bachmann-Bupp syndrome (BABS). Early patient treatments suggest the drug, DFMO, may ease severe symptoms by targeting the underlying genetic malfunction. Researchers have already treated a handful of patients with encouraging results, but progress has been slowed by regulatory and logistical hurdles.
